-
Product Insights
Port Everglades Next Generation Clean Energy Center
Port Everglades Next Generation Clean Energy Center is a thermal project located in Florida, United States. The project is owned by Florida Power & Light Co. The project came online in 2016. Empower your strategies with our Port Everglades Next Generation Clean Energy Center report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Helios CELMoD in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Helios CELMoD in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Helios CELMoD in Solid Tumor Drug Details: The therapeutic candidate...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Efzimfotase Alfa in Hypophosphatasia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Efzimfotase Alfa in Hypophosphatasia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Efzimfotase Alfa in Hypophosphatasia Drug Details: ALXN-1850 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Osivelotor in Sickle Cell Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Osivelotor in Sickle Cell Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Osivelotor in Sickle Cell Disease Drug Details: Osivelotor is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TAK-881 in Primary Immune Deficiency (PID)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TAK-881 in Primary Immune Deficiency (PID) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TAK-881 in Primary Immune Deficiency (PID) Drug Details: TAK-881...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SBT-777101 in Hidradenitis Suppurativa
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SBT-777101 in Hidradenitis Suppurativa report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SBT-777101 in Hidradenitis Suppurativa Drug Details: SBT-777101 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATA-2271 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATA-2271 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATA-2271 in Solid Tumor Drug Details: ATA-2271 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rifaximin SSD in Hepatic Encephalopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rifaximin SSD in Hepatic Encephalopathy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rifaximin SSD in Hepatic Encephalopathy Drug Details: Rifaximin soluble solid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rifaximin SSD in Sickle Cell Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rifaximin SSD in Sickle Cell Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rifaximin SSD in Sickle Cell Disease Drug Details: Rifaximin...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SBT-777101 in Rheumatoid Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SBT-777101 in Rheumatoid Arthritis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SBT-777101 in Rheumatoid Arthritis Drug Details: SBT-777101 is under development for the...